| 000 | 01481 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513110753.0 | ||
| 264 | 0 | _c19970114 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0959-6658 | ||
| 024 | 7 |
_a10.1093/glycob/6.1.33 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGillard, B K | |
| 245 | 0 | 0 |
_aPathways of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments. _h[electronic resource] |
| 260 |
_bGlycobiology _cJan 1996 |
||
| 300 |
_a33-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcylation |
| 650 | 0 | 4 | _aAdrenal Cortex Neoplasms |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCarcinoma, Small Cell |
| 650 | 0 | 4 |
_aCeramides _xbiosynthesis |
| 650 | 0 | 4 |
_aEndosomes _xmetabolism |
| 650 | 0 | 4 |
_aG(M1) Ganglioside _xmetabolism |
| 650 | 0 | 4 |
_aGalactose _xmetabolism |
| 650 | 0 | 4 |
_aGlucosamine _xmetabolism |
| 650 | 0 | 4 |
_aGlycosphingolipids _xbiosynthesis |
| 650 | 0 | 4 |
_aGolgi Apparatus _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aSerine _xmetabolism |
| 650 | 0 | 4 |
_aSphingosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aVimentin _xpharmacology |
| 700 | 1 | _aHarrell, R G | |
| 700 | 1 | _aMarcus, D M | |
| 773 | 0 |
_tGlycobiology _gvol. 6 _gno. 1 _gp. 33-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/glycob/6.1.33 _zAvailable from publisher's website |
| 999 |
_c8982888 _d8982888 |
||